Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BACR & ECMC: Therapeutic interventions for cancer prevention /
Tumour metabolism in chemoprevention

18th - 19th Jul 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.08.16
Views: 1765
Rating:

Dr Farhat Din – The University of Edinburgh, Edinburgh, UK

Dr Din speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about her research into the metabolic processes of aspirin in cancer cells

Using organoid models, she reports on the mechanisms by which aspirin inhibits mTOR signalling and protein regulation. 

Dr Din describes the additional impacts of diet, exercise and genetic susceptibility on tumour metabolism, and the population-level outcomes that wider adoption of chemoprevention could contribute towards.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation